Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI - RTP United States | 2 | 647 |
|
Tempus AI - CHI United States | 2 | 647 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
PathGroup United States | 73 | 505 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
GTC-Hematology Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 254 |
|
Genomic Testing Cooperative, LCA United States | 1 | 247 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 362 | 227 |
|
PreventionGenetics, part of Exact Sciences United States | 156 | 73 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
NeoTYPE® Discovery Profile for Solid Tumors NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States | 1 | 315 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.